aoa

Linezolid (PNU-100766), the first of the oxazolidinone class, is a synthetic antibiotic used for the therapy of infections resulted from multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and streptococcus. The drug takes effect as the inhibitor of the initiation of bacterial protein synthesis.

MAOA-IN-1 (compound 15) is an orally-active monoamine oxidase A (MAOA) inhibitor with cytotoxic effects on prostate cancer cells. It exhibits Caco-2 permeability and reduced central nervous system (CNS) permeability, indicating potential utility in anti-cancer and anti-inflammatory research [1].

Nialamide (Nialamid) is an MAO inhibitor that is used as an antidepressive agent.